Generic Drugs Market Outlook – Patent Expiries to Drive Future Growth

Mumbai, Maharashtra, September 13, 2017 /– Global market intelligence firm, Netscribes, Inc. released its latest report on the ‘Generic Drugs Market in India 2017’. The report states that the large number of drug patents slated to expire in the next few years will lead to the introduction of several new generics in the market.

Netscribes’ latest market research report titled Generic Drugs Market in India 2017 covers the current and future state of the generics market in the country. Demand for generics is expected to increase as patients shift from the more expensive branded drugs to the lower priced generics. Various initiatives from the government to increase the usage of generics instead of branded drugs, wherever possible, are also helping in the growth of the market. Setting up of a large number of Jan Aushadhi stores is making generics more accessible. Moreover, government’s proposal in Jul 2016 whereby physicians would have to mention generic names of drugs instead of names of branded drugs is expected to further boost the market.

Generic drug manufacturers operating in India have a distinct cost advantage when it comes to manufacturing. The low manufacturing costs in the country enable Indian companies to manufacture generic drugs at costs lower than the cost at which companies operating in regulated markets manufacture. Consequently, this has created a huge export opportunity for Indian companies. The US is one of the largest importers of generic drugs from India. Recently, regulatory warnings from foreign regulatory bodies such as the USFDA regarding lapses in product quality and for not adhering to stipulated manufacturing standards have led to a negative perception of generics manufactured in India. The industry, however, realizes the importance of these export markets and is taking remedial steps to ensure that such negative perceptions are removed.

Customizations Available
With the given market data, Research on India offers customizations according to specific needs. Write to us at support@researchonindia.com

For more details on the content of each report and ordering information please contact:

Phone: +91 33 4027 6243/6222; +91 33 4027 6200/6207; +91 22 4098 7600
E-Mail: support@researchonindia.com ; info@netscribes.com

Notes to Editor

About Netscribes

Netscribes (www.netscribes.com) is a global market intelligence and content management firm with services across the research and information value chain. Venture-funded by US and Singapore private equity firms, the company provides tactical and actionable insights to its clients and enables effective decision-making and strategic implementation.

For more information please write to info@netscribes.com

Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024

New Delhi, Delhi, September 7, 2017 /– Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.

Long-term Growth Projection and Development:

– Sanofi to Acquire Protein Sciences Corporation
– It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024
– Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season
– It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024

– BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine

Complete Report @ http://www.dpiresearch.com/report-details.php?P_ID=110

“Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an in-depth analysis of the flu vaccination pattern in both Children and Adults in the United States. It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the US flu vaccine market such as Sanofi Pasteur, GSK and Seqirus. The major market players are evaluated on various parameters such as company overview, product outlook, latest development & trends and sales analysis of flu vaccine market from 2011 to 2022. The report also entails major drivers and inhibitors in the US flu vaccine market.

Key Topics Covered in the Report

– Market Overview: United States Flu Vaccine Market (2010 – 2024)

– United States Number of Persons Vaccinated with Flu Vaccine (2010 – 2024)

– United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification

– Reimbursement & Regulatory System in the US Flu Vaccine Market

– Mergers, Acquisitions, Key Agreements & Collaborations

– Promising Flu Vaccine in Clinical Development

– Flu Vaccine Clinical Trial Insights by Phase, Company & Country

– Key Drivers and Inhibitors of the US Flu Vaccine Market

– Key Companies Analysis

Major Flu Vaccines Covered Under This Report Are:

– Fluzone High-Dose- Fluzone Quadrivalent

– Intradermal (ID) Trivalent

– Vaxigrip

– Fluarix Quadrivalent

– Flulaval Quadrivalent

– Flucelvax Quadrivalent

– Afluria Quadrivalent

– Agrippal- Fluad

– Fluvirin

– Fluvax

Key Companies Covered in This Report:

– Seqirus

– Sanofi Pasteur

– GlaxoSmithKline(GSK)

Notes to Editor

DPI Research is a business solutions firm which offer bespoke market research reports, custom research solutions and consulting across multi geographies and industry verticals. We deliver wide range of cutting-edge research solutions that helps organizations in making better decisions of the business to business needs.

DPI Research provides high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to use advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for the business research led by a team of dynamic industry experts. DPI Research provides a real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reach across the globe with global standards from established markets in the North America and Europe to emerging markets in South America, Asia-Pacific, Middle East and Africa to provide the best business solutions.

Global Vitamin Ingredients Market Is Expected To Reach USD 8.50 Billion in 2024

New York, New York, September 6, 2017 /– Vitamin is a nutritional compound that removes some sort of deficiency from body. Since vitamins can’t adjust with the body so they are consumed in small quantity. Huge demand of dietary supplements is fuelling the growth of vitamin ingredient market. On the basis of application, animal feeds are accounted for having the largest market share of around 45% globally. Global Vitamin ingredients market size is expected to gain USD 8.50 billion by 2024, growing at a CAGR of approximately 5.0% over the forecast period 2016-2024. Government of various countries are taking initiatives to make people aware of dietary supplements such as the Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) have made several efforts to make people aware of the importance of vitamin D in terms of health similarly government of other countries are also trying to make people aware of vitamin deficiency and also providing a solution to them.

Request for TOC@ https://www.goldsteinresearch.com/toc-request/global-vitamin-ingredient-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024

Market Segmentation

  • On the basis of products
    • Vitamin A
    • Vitamin B
    • Vitamin C
    • Vitamin D
    • Vitamin E
    • Vitamin K
  • On the basis of mode of consumption
    • Pills
    • Powders
    • Creams
    • Liquids
  • On the basis of application
    • Pharmaceuticals
    • Food and beverage
    • Cosmetics
    • Animal feeds
    • Others.
  • On the basis of Region
    • North America (US, Canada)
    • Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe)
    • Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa)
    • Latin America (Brazil, Mexico and Rest of Latin America)
    • Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific)
    • Rest of the World{Market Share (%), Market Size (USD Billion)}

Global Vitamin Ingredients Market Outlook 2024” contains detailed overview of the global vitamin ingredients market in terms of market segmentation by sources type, by livestock application type, by industrial application type.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.

This market report also includes provides competitive outlook of some of the major players of the global vitamin ingredients market which includes profiling of companies of The BASF, Bayer, Amway, DSM, Dupont, Lonza, AIE Pharmaceutical, Aland (Jiangsu) Nutraceuticals, Atlantic Essential Products, Bactolac Pharmaceutical etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.

Overall, the report represents comprehensive synopsis on the global vitamin ingredients market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Notes to Editor

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Backed up by reliable research and impactful statistics, our business solutions empower our clients to grow at a fast pace despite unsettling fluctuations in the market. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

Send Us Sample Request@ https://www.goldsteinresearch.com/request-sample/global-vitamin-ingredient-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024

www.goldsteinresearch.com

Global physiotherapy equipment market size reached USD 15.6 billion in 2016 and is predicted to garner USD 25.0 billion by the end of 2024

New York, New York, September 6, 2017 /– Physiotherapy is a treatment that focuses on physical methods to prevent injuries such as massage, heat treatment and different form of exercises in spite of surgeries or other harmful operations. Physiotherapy is a boom when it comes to chronic disease which last for longer time such as cancer, asthma, arthritis etc. Increase in ageing population is giving rise to cardiovascular, muscular and neurological disorders. Physiotherapy is the best treatment for prevention of these disorders as it helps the patients to avoid injuries and diseases by giving them massage heat treatment. Global physiotherapy equipment market size reached USD 15.6 billion in 2016 and is predicted to garner USD 25.0 billion by the end of 2024 witnessing a promising CAGR of 7.0% over the forecast period i.e. 2016-2024.Geographically, North America physiotherapy equipment market dominated the global market and accounted USD 6.0 billion in 2016. On the basis of products which are hydrotherapy, Cryotherapy, CPM, Electric stimulation, heat therapy and ultrasounds etc. In terms of revenue, Ultrasound is the largest revenue generating physiotherapy segment in the year 2016.

Request for TOC@ https://www.goldsteinresearch.com/toc-request/global-physiotherapy-equipment-market-global-opportunity-and-demand-analysis-market-forecast-2016-2024

Market Segmentation

  • On the basis of products
    • Hydrotherapy
    • Cryotherapy
    • Continuous Passive Motion (CPM)
    • Electric Stimulation
    • Heat Therapy
    • Therapeutic Exercises
    • Ultrasound
    • Others (Laser Therapy, Wax Therapy, and Traction)
  • On the basis of application
    • Cardiovascular and Pulmonary
    • Musculoskeletal
    • Neurology
    • Pediatric
    • Others (Sports, Women Health, and Palliative Care)
  • On the basis of end users
    • Hospitals
    • Clinics
    • Diagnostic Labs
    • Others (Home health centers, schools and rehabilitation centre)
  • On the basis of region
    • North America (U.S., Canada)
    • Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe)
    • Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa)
    • Latin America (Brazil, Mexico and Rest of Latin America)
    • Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific)
    • Rest of the World

Global Physiotherapy Equipment Market Outlook 2024” contains detailed overview of the global physiotherapy equipment market in terms of market segmentation by product type, by application type, end user type.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.

This market report also includes provides competitive outlook of some of the major players of the global physiotherapy equipment market which includes profiling of companies BTL Industries DJO Global, Enraf-Nonius, EMS Physio, Isokinetic, Patterson Medical, Dynatronics Corporation, A.AlgeoLimited, Whitehall Manufacturing etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.

Overall, the report represents comprehensive synopsis on the global physiotherapy equipment market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Notes to Editor

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Backed up by reliable research and impactful statistics, our business solutions empower our clients to grow at a fast pace despite unsettling fluctuations in the market. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

Send Us Sample Request@ https://www.goldsteinresearch.com/request-sample/global-physiotherapy-equipment-market-global-opportunity-and-demand-analysis-market-forecast-2016-2024

www.goldsteinresearch.com

Global Parkinson’s Disease Drugs Market to Reach Approximate Value of US$ 5 Billion by 2022

Noida, Uttar Pradesh, September 6, 2017 /– Parkinson’s disease is a chronic and progressive disorder of the nervous system. This disease is caused by the lack of dopamine in the brain. According to Parkinson’s Foundation, more than 10 Million people are living with Parkinson’s disease worldwide. Out of these, nearly 1 Million affected people are found in America. Various drugs are used for controlling the symptoms of Parkinson’s disease.

According to our report, “Global Parkinson’s Disease Drugs Market Outlook 2022“, the Global Parkinson’s Disease Drugs Market is expected to grow at a CAGR of around 4% from 2016 – 2022. The market segmentations by type of therapy and by geography have been mentioned in the report. The global Parkinson’s disease drugs market has been segmented on the basis of type of therapy into levodopa therapy, dopamine agonist therapy, MAO-B inhibitor therapy, COMT inhibitor therapy and other type of therapies. Amongst all the types of therapies, levodopa therapy is the potent for the treatment of Parkinson’s disease.

Based on geography, the report divides the market into North America, Europe, and Asia-Pacific. In 2016, North America accounted for the largest share in the global market for Parkinson’s disease drugs. Moreover, the report also highlights various mergers and acquisitions taking place in the global Parkinson’s disease drugs industry. Pipeline of Parkinson’s disease drugs have also been mentioned in the report.

The report also covers the key players of the global Parkinson’s disease drugs market. For every player, a brief business overview and key financials has been provided. The product portfolio, product pipeline and recent developments of each player have also been listed down. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the Global Parkinson’s disease drugs market.

Some of the key findings of the report are:

– Stem Cell Therapies – Revolutionizing Parkinson Treatment

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM914.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

Notes to Editor

About RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.

Pediatric Proton Therapy Market is expected to cross US$ 700 Million

Atlanta, Georgia, August 28, 2017 /– By the year 2021, Pediatric Proton Therapy Market is expected to cross US$ 700 Million. When you find out your child has cancer or another hostile tumor; you’re extremely focused on the immediate cure. Then the question arises like, which way of treatment? – What combination of surgery? Weather it “Chemotherapy or Radiation”- will greatly help your child survival, it’s also important to know how treatments they undergo now may affect them in future when they will become adults.

Even if treating cancer with a low risk of side effects is the main concern for every patient, it’s especially important when treating cancer in children. Therefore, for a lot of patients with pediatric cancer, proton therapy needs exceptional assurance.

In the Proton therapy the technology is different – its machine is three stories high and weighting up of 100 tons consists of special housing within a treatment facility to hold the equipment and convey the proton beams. “Gantry” a rotating device releases protons to the tumor from different angles.

In that cure room, patients are placed on a table or in a specific chair. MRI or CT scans are taken before each treatment to make sure exact positioning.

For More Information: http://www.renub.com/global-pediatric-proton-therapy-market-and-forecast-10-countries-market-data-patients-treated-1196-p.php

United States leads the Pediatric Proton Therapy Market Globally

The United States leads the proton therapy centers in the world because of its enormous investment in the growth of therapy centers as well as its drawn out history of proton therapy. 23 proton beam centers are operating in the United States. Proton therapy costs almost twice as much as traditional X-ray radiation in the United States. The United States Pediatric Proton Therapy Market is categorized in five age groups i.e. (<1 years), (1 to 4 years), (5 to 9 years), (10 to 14 years), (15 to 18 years).

Accelerating Proton Therapy Drives Pediatric Cancer Market in Europe

Germany captures the most of the market shares of Europe Pediatric Proton Therapy Market. In the year 2010, France had the maximum number of market share but it lost its position and went to the fourth position in 2016. Growing number of cancer diagnosed pediatric patients in Europe will compel many countries in Europe to develop proton therapy centers. The other countries from Europe who are doing lot of work in pediatric proton therapy segment are United Kingdom, Sweden, Switzerland, and Czech Republic. Germany and France deal in Pediatric Proton Therapy and diagnose the patients.

Request a free sample copy of the report: http://www.renub.com/contactus.php

Japan leads the Pediatric Proton Therapy Market in Asia

Pediatric Proton therapy technology has immense potential as is evident in the increasing number of proton therapy centers across the Asia. Japan has already established their benchmark for the treatment of pediatric patient with proton therapy. China and South Korea both are developing their pediatric Proton Therapy centers.

Key Players in Pediatric Proton Therapy Market

The key players who played a very crucial in the development and innovation in devices in the field of pediatric proton therapy were-

– Varian Medical Systems
– Mitsubishi
– Hitachi
 IBA

The report studies the Proton Therapy Market & Patients Number for 36 Type of Tumors in USA

– Glioma, Low Grade
– Glioma, High Grade
 Medulloblastoma
– Ependymoma
– ATRT
– Germinoma, Pure
– Germ Cell Tumor
– Craniopharyngioma
 PNET
– Pineoblastoma
– Chordoma/Chondrosarcoma
– Meningioma
– AVM
– Adenoma
– Choroid Plexus Carcinoma
 Retinoblastoma
– Osteosarcoma
– Ewing Sarcoma
– Rhabdomyosarcoma
– Other Sarcoma, High Grade
– Other Sarcoma, Low Grade
– Teratoma
– Neuroblastoma
– Ganglioglioma
– Wilm’s Tumor
– Carcinoma (non-CPC)
– Lymphoma, Hodgkin’s
– Lymphoma, Non-hodgkin’s
– Leukemia
– Desmoid
 Melanoma
 Pineal Parenchymal Tumor
– Esthesioneuroblastoma
– Angiofibroma
– Extrarenal Rhabdoid Tumor
– Others – Market & Forecast

Web: www.renub.com

For More Information: http://www.renub.com/pediatric-proton-therapy-market-is-growing-worldwide-due-to-pediatric-cancer-cases-and-innovation-in-technology-48-nd.php

Notes to Editor

Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.

Gujarat CM Vijay Rupani to inaugurate Dr Dharmendra Kumar’s Swasth Zindagi – Medical Camp at Surat by R K HIV Aids Centre

The Chief Minister of Gujarat Shri Vijay Rupani will inaugurate ‘Swasth Zindagi’, one of the largest medical camps to be held in India.

This mega social event is being held at Surat on 29th October 2017 and will be attended by over 5000 doctors from all over India.

On this occasion many government officials, IAS, IPS and Cabinets Ministers and other Ministers from the Central government and State governments have confirmed their attendance.

The R K HIV AIDS Research & Care Centre had created a ‘Guinness Book of World Records’ for the “Largest Sexual Health Awareness” the mega healthcare movement, ‘Swasth Zindagi’, one of the largest medical camps which was held on 19th Feb 2017 at the MMRDA Grounds, BKC in Mumbai.

Over 52 hospitals from all over Maharashtra, thousands of doctors, paramedical doctors and volunteers joined the movement catering to the needy, who are unaware of the benefits and medical schemes they are eligible for.

The same feet is now going to be repeated in Surat on 29th October 2017 with Gujarat CM Vijay Rupani lighting the lamp at the inauguration of the camp which will be held from 6am to 6pm.

Prominent among them are Vijay Rupani – Chief Minister Gujarat, J P Nadda – Health Minister Govt of India, Annant Geete – Minister of Heavy Industries and Public Enterprise, Smriti Irani – Minister of Textiles, Dharmendra Pradhan – Minister of State (Independent Charge) for Petroleum and Natural Gas, Faggan Singh Kulaste – Health Minister (MOS), Anupriya Patel – Health Minister (MOS), and many more.

Bollywood personalities like actor/producer Jitendra Kapoor and music director Shravan Rathod have confirmed their presence.

“The biggest challenge in implementing the primary health care principles is of equitable distribution of health care to all. The rural masses and urban slum dwellers are most vulnerable to lack of access to health care, and RK HIV AIDS Research & Care Centre aims to bridge this gap,” explains Dr Dharmendra Kumar.

“The underprivileged and the slum dwellers in India continue to have poor access to basic determinants of good health as well as to the curative services from government sources during illness as the masses are indifferent or not aware of the various medical schemes and benefits available to them. ‘Swasth Zindagi’ by RK HIV AIDS is one step towards this cause”, said Dr Dharmendra Kumar, Chairman, RK HIV AIDS Research & Care Centre.

All major diseases will be covered at the medical camp including cardiac, kidney or liver ailments, ENT ailments, HIV, cancer, heart and lung ailments etc.

Over the past five years, R K HIV has successfully conducted 7971 medical camps in which over 37,71,578 patients were screened in states like Gujarat, Maharashtra, Goa, MP, Chhattisgarh, Jharkhand, Bihar, Rajasthan, Orissa.

In last two years, R. K. HIV has covered 4.5 lac people under the scheme of Pradhan Mantri Jeevan Suraksha Yojna.

The camp in Mumbai brought together the who’s who of the medical fraternity under one umbrella. Hospitals like JJ, Sion hospital, KEM, Cooper, Dr.DY Patil Medical College and Hospital, Surya hospital along with pharma companies like, Alkem Pharma, Aristo Pharma Ashoka Drugs and Chemicals Pharma Co. and Social organizations like Wockhardt Foundation, Vande Matram, Rizwan Adatia Foundation, NCORD, Swarlipi Charitable Trust, DRVA Charitable Trust, SPAP Media along with Wellness TV & My Dentist supported this noble cause. The mega event was also supported by the Mumbadevi Charitable Trust and Vaishnav Charitable Trust among others.

Throughout the year R K HIV AIDS Research & Care Centre will be undertaking several developmental programs like adopting about 300 villages across India this year.

R K HIV has taken up the mantle to train one lakh women across Maharashtra, Gujarat, West Bengal, Orissa, Jharkhand, Uttar Pradesh, etc to teach them how to tackle various medical emergencies, health issues, etc.

In a first-of-its-kind initiative, the mega-event at Surat will also witness the free distribution of medical insurance worth Rs. 2 lakh to every person registered at the Medical camp under the Pradhan Mantri Suraksha Bima Yojana (PMSBY).

More than 50,000 spectacles will also be distributed to the masses, said Dr Dharmendra Kumar of R K HIV Aids.